Hypertension in solid organ transplant recipients

Annals of Transplantation

Volumn 17, Issue 1, 2012, Pages 100-107

  Zbroch, Edyta ^a   Małyszko, Jolanta ^a   Myśliwiec, Michał ^a   Przybylowski, Piotr ^b   Durlik, Magdalena ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Heart; Hypertension; Liver transplantation; Renal

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; GLUCOCORTICOID; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTERIOVENOUS FISTULA; BLOOD PRESSURE; DRUG ANTAGONISM; GLOMERULONEPHRITIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART ARRHYTHMIA; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY ARTERY STENOSIS; KIDNEY GRAFT; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; PATHOGENESIS; PROTEINURIA; REVIEW;

EID: 84859394020     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.882641     Document Type: Review

References (62)

1. Ponticelli C, Cucchiari D, Graziani G: Hypertension in kidney transplant recipients. Transpl Int, 2011; 24: 523-33.
2. Wadei HM, Textor SC: Hypertension in the kidney transplant recipient. Transplant Rev (Orlando), 2010; 24: 105-20.
3. Hillebrand U, Suwelack BM, Loley K et al: Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients. Transpl Int, 2009; 22: 1073-80.
4. Dunn BL, Teusink AC, Taber DJ et al: Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies. Ann. Pharmacother, 2010; 44: 1259-70.
5. Ducloux D, Motte G, Kribs M et al: Hypertension in renal transplantation: donor and recipient risk factors. Clin Nephrol, 2002; 57: 409-13.
6. Włodarczyk Z, Glyda M, Kościanska L et al: Prevalence of arterial hypertension following kidney transplantation-a multifactorial analysis. Ann Transplant, 2003; 8: 43-46.
7. Guidi E, Menghetti D, Milani S et al: Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol, 1996; 7: 1131-38.
8. Zbroch E, Maciorkowska D, Małyszko J, Myśliwiec M: Blood pressure control in dialyzed patients Arterial Hypertension, 2011; 14: 169-76.
9. Zbroch E, Maciorkowska D, Małyszko J, Myśliwec M: Kontrola ciśnienia te{ogonek}tniczego u chorych dializowanych otrzewnowo. Post Nauk Med, 2010; 23: 181-87.
10. Schlaich MP: Sympathetic activation in chronic kidney disease: out of the shadow. Hypertension, 2011; 57: 683-85.
11. Linenberg G, Blankestijn PJ, Oey L et al: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med, 1999; 340: 1321-28.
12. Audard V, Matignon M, Hemery F et al: Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant, 2006; 6: 95-99.
13. Bruno S, Remuzzi G, Ruggenenti P: Transplant renal artery stenosis. J Am Soc Nephrol, 2004; 15: 134-41.
14. Goodwin JE, Zhang J, Geller DS: A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension. J Am Soc Nephrol, 2008; 19: 1291-99.
15. Ratcliffe PJ, Dudley CR, Higgins RM et al: Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet, 1996; 348: 643-48.
16. Crespo-Leiro MG: Arterial hypertension. Transplant Proc, 2002; 34: 127-29.
17. Curtis JJ, Luke RG, Jones P, Diethelm AG: Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med, 1988; 85: 134-38.
18. Bohlke M, Barcellos FC, Rocha M et al: Predictors of hypertension following successful renal transplantation: a population-based study. Transplant Proc, 2009; 41: 3743-46.
19. Curtis JJ: Posttransplant hypertension. Transplant Proc, 1998; 30: 2009-11.
20. Huysmans FT, Hoitsma AJ, Koene RA: Factors determining the prevalence of hypertension after renal transplantation. Nephrol Dial Transplant, 1987; 2: 34-38.
21. Ortega LM, Materson BJ: Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment. J Am Soc Hypertens, 2011; 5: 128-36.
22. Mancia G, De Backer G, Dominiczak A et al: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens, 2007; 25: 1105-87.
23. Chobanian AV, Bakris GL, Black HR et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003; 289: 2560-72.
24. Available from http://www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx.
25. Małyszko J, Małyszko J, Bachórzewska-Gajewska H et al: Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications. Transplant Proc, 2009; 41: 3069-72.
26. Zbroch E, Głowińska I, Maciorkowska D et al: Blood pressure control in kidney allograft recipients. Arterial Hypertension, 2011; 15: 283-89.
27. Hedayati SS, Elsayed EF, Reilly RF: Non-pharmacological aspects of blood pressure management: what are the data? Kidney Int, 2011; 79: 1061-70.
28. Wadei HM, Amer H, Taler SJ et al: Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. J Am Soc Nephrol, 2007; 18: 1607-15.
29. Kasiske BL, Chakkera HA, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol, 2000; 11: 1735-43.
30. Stigant CE, Cohen J, Vivera M, Zaltzman JS: ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis, 2000; 35: 58-63.
31. Philipp T, Martinez F, Geiger H et al: Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant, 2010; 25: 967-76.
32. Ahsan N, Hricik D, Matas A et al: Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation, 1999; 68: 1865-74.
33. Johnson RW, Kreis H, Oberbauer R et al: Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation, 2001; 72: 777-86.
34. Fernández-Fresnedo G, Gago-Fraile M, Gómez-Alamillo C et al: Risk of cardiovascular disease associated with refractory hypertension in renal transplant recipients. Transplant Proc, 2010; 42: 2908-9.
35. Rao VK: Posttransplant medical complications. Surg Clin North Am, 1998; 78: 113-32.
36. Taylor DO, Stehlik J, Edwards LB et al: Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant, 2009; 28: 1007.
37. Bortolotto LA, Silva HB, Bocchi EA et al: Longterm course and complications of arterial hypertension after heart transplantation. Arq Bras Cardiol, 1997; 69: 317-21.
38. Przybylowski P, Malyszko J, Malyszko JS et al: Blood pressure control in orthotopic heart transplant and kidney allograft recipients is far from satisfactory. Transplant Proc, 2010; 42: 4263-66.
39. Weiss ES, Nwakanma LU, Patel ND, Yuh DD: Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant, 2008; 27: 184-91.
40. Scherrer U, Vissing SF, Morgan BJ et al: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med, 1990; 323: 693-99.
41. Passauer J, Lassig G, Bussemaker E et al: Reduced endothelin-1-and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients. Kidney Int, 2004; 65: 1782-89.
42. Sayegh MH, Lazarus JM: Renal parenchymal disease and hypertension. In: Current Management of Hypertension and Vascular Disease. Cooke JP, Frohlich ED (eds.), Decker, Philadelphia, 1992; 76.
43. Textor SC, Canzanello VJ, Taler SJ et al: Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc, 1994; 69: 1182.
44. Shiba N, Chan MC, Kwok BW et al: Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant, 2004; 23: 155-59.
45. Margreiter R: Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet, 2002; 359: 741-46.
46. Gonwa T, Mendez R, Yang HC et al: Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation, 2003; 75: 1213-20.
47. Groetzner J, Kaczmarek I, Landwehr P et al: Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg, 2004; 25: 333-41.
48. Groetzner J, Kaczmarek I, Schulz U et al: VENINAHTx-Investigators. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation, 2009; 87: 726-33.
49. Gonwa TA: Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transpl, 2001; 7(Suppl.1): S22-26.
50. Jain A, Reyes J, Kashyap R et al: What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term followup of the first 1000 patients. Ann Surg, 1999; 230: 441-48.
51. Canzanello VJ, Textar SC, Taler SJ et al: Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506). Liver Transpl Surg, 1998; 4: 328-34.
52. Hryniewiecka E, Zegarska J, Paczek L: Arterial Hypertension in Liver Transplant Recipients. Transplant Proc, 2011; 43: 3029-34.
53. Fernández-Miranda C, Sanz M, dela Calle A et al: Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation. Transpl Int, 2002; 15: 556-62.
54. Neal DA, Brown MJ, Wilkinson IB, Alexander GJ: Mechanisms of hypertension after liver transplantation. Transplantation, 2005; 79: 935-40.
55. Textor SC: De novo hypertension after liver transplantation. Hypertension, 1993; 22: 257-67.
56. Benoit JN, Korthuis RJ, Granger DN, Battarbee HD: Splanchnic hemodynamics in acute and chronic portal hypertension. In: Bomzon A, Blendis LM (eds.), Cardiovascular complications of liver disease. Boca Raton: CRC, 1990: 179-206.
57. Textor SC, Taler SJ, Canzanello VJ et al: Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl, 2000; 6: 521-30.
58. McGuire BM, Rosenthal P, Brown CC et al: American Society of Transplantation. Long-term management of the liver transplant patient: recommendations for the primary care doctor. Am J Transplant, 2009; 9: 1988-2003.
59. Ojo AO, Held PJ, Port FK et al: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med, 2003; 349: 931-40.
60. Rossetto A, Bitetto D, Bresadola V et al: Cardiovascular risk factors and immunosuppressive regimen after liver transplantation. Transplant Proc, 2010; 42: 2576-78.
61. Strozecki P, Adamowicz A, Kozlowski M et al: Progressive arterial stiffening in kidney transplant recipients. Ann Transplant, 2011; 16: 30-35.
62. Halawa A: The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers. Ann Transplant, 2011; 16:90-98